Skip to content

H2020HORIZONFP7

Boston Scientific Limited

Country
IEIreland
Defence projects
0
Projects, all programmes
17
As coordinator
0
EU contribution (CORDIS)
EUR 4,768,995
Active
2013 to 2023

Projects

17 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
MedDevDocDoctorate Career Development and Mobility Studentships in Medical Device Research and Advancements: Enhancing the CÚRAM Industry-Academia Training InitiativeHORIZON2023Associated partnerEUR 0
NewlifeNew remote non-invasive monitoring solutions for ensuring the health of mothers and babies before and after birthHORIZON2023ParticipantEUR 62,125
ELR-SCARA novel multi-functional elastin-like recombinant hydrogel for the prevention of scar tissue formation following a myocardial infarction: ELR-SCARHORIZON2022ParticipantEUR 879,145
MedTrainPlusMedTrain+: Postdoctoral Career Development and Mobility Fellowships in Medical Device Research Evolving the CÚRAM Industry-Academia Training InitiativeHORIZON2022Associated partnerEUR 0
BRAV3Computational biomechanics and bioengineering 3D printing to develop a personalized regenerative biological ventricular assist device to provide lasting functional support to damaged heartsH20202020ParticipantEUR 471,750
Moore4MedicalAccelerating Innovation in Microfabricated Medical DevicesH20202020ParticipantEUR 59,000
GrapheneCore3Graphene Flagship Core Project 3H20202020ParticipantEUR 250,000
UWIPOM2ULTRA-EFFICIENT WIRELESS POWERED MICRO-ROBOTIC JOINT FOR HEALTH APPLICATIONSH20202019ParticipantEUR 365,475
DELIVERDELIVERy of advanced therapies for diabetes training networkH20202019ParticipantEUR 0
BioImplant ITNEuropean Training Network to develop Improved Bioresorbable Materials for Orthopaedic and Vascular Implant ApplicationsH20202019ParticipantEUR 0
FIT4FoFMaking our Workforce Fit for the Factory of the FutureH20202018ParticipantEUR 118,750
GrapheneCore2Graphene Flagship Core Project 2H20202018ParticipantEUR 0
InSilcInSilc: In-silico trials for drug-eluting BVS design, development and evaluationH20202017ParticipantEUR 305,580
OPTOGENERAPYOptogenetic Protein Therapy for Multiple SclerosisH20202017ParticipantEUR 805,880
COMPOSITIONEcosystem for Collaborative Manufacturing Processes – Intra- and Interfactory Integration and AutomationH20202016ParticipantEUR 509,401
DRIVEDiabetes Reversing Implants with enhanced Viability and long-term EfficacyH20202015ParticipantEUR 715,020
AMCAREAdvanced Materials for Cardiac Regeneration (AMCARE)FP72013ParticipantEUR 226,868

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.